Ignite Creation Date:
2024-05-06 @ 7:16 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02504892
Status:
TERMINATED
Last Update Posted:
2019-03-22
First Post:
2015-07-21
Brief Title:
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome BHD-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
150166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
Ramaprasad Srinivasan MD
Responsible Party Title:
Principla Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Institute NCI
Old Name:
None
Old Organization:
None